Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria

The emergence of antimicrobial-resistant bacteria is an increasingly serious threat to global health, necessitating the development of innovative antimicrobials. Here we report the development of a series of CRISPR-Cas13a-based antibacterial nucleocapsids, termed CapsidCas13a(s), capable of sequence...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiga, Kotaro, Tan, Xin-Ee, Ibarra-Chávez, Rodrigo, Watanabe, Shinya, Aiba, Yoshifumi, Sato’o, Yusuke, Li, Feng-Yu, Sasahara, Teppei, Cui, Bintao, Kawauchi, Moriyuki, Boonsiri, Tanit, Thitiananpakorn, Kanate, Taki, Yusuke, Azam, Aa Haeruman, Suzuki, Masato, Penadés, José R., Cui, Longzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287087/
https://www.ncbi.nlm.nih.gov/pubmed/32523110
http://dx.doi.org/10.1038/s41467-020-16731-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287087/
https://www.ncbi.nlm.nih.gov/pubmed/32523110
http://dx.doi.org/10.1038/s41467-020-16731-6

Ejemplares similares